Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
-86,415
Put/Call ratio
1297%
SEC-reported price per share
$2.48
Number of holders
72
Value change
-$212,803
Number of buys
32
Open additional details 1 more signal available
Number of sells
38
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,227,200

Security key

00509G209

Report period

Q3 2024

Institutions

72

Top holders

10

Ownership snapshot

Top reported holders of ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Sands Capital Ventures Di...
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5 13F Highest disclosed value: $36,135,592 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $36.14M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
Sands Capital Ventures Discovery ... $11.86M
Paul B. Manning $2.28M
Robert D. Hardie $2.28M
RA CAPITAL MANAGEMENT, L.P. $36.14M
Sands Capital Alternatives, LLC $8.27M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Sands Capital Ventures Discovery Fund III, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$11,859,300
3,417,075 shares
— 06 Jul 2021
Paul B. Manning
3/4/5
10%+ Owner
—
denominator unverified
$2,283,603
657,985 shares
— 06 Jul 2021
Robert D. Hardie
3/4/5
10%+ Owner
—
denominator unverified
$2,283,603
657,985 shares
— 06 Jul 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$36,135,592
14,932,063 shares
— 30 Jun 2024
Sands Capital Alternatives, LLC
13F
Company
13F
—
denominator unverified
$8,269,322
3,417,075 shares
— 30 Jun 2024
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$8,149,636
3,367,618 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
72
Shares
43,605,225
Rows available
72
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
81
Q3 2024 holders
72
Holder diff
-9
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .